Zobrazeno 1 - 9
of 9
pro vyhledávání: '"311.Disorders of Platelet Number or Function: Clinical and Epidemiological"'
Autor:
John D. Crispino
Publikováno v:
Blood
Background: Immune thrombocytopenia (ITP) is an acquired autoimmune disorder against platelets characterized by a low platelet count and increased bleeding risk. ITP is likely to rise from defective immune tolerance in addition to a triggering event,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ecf7621fe031187278cf78c95def70
https://pubmed.ncbi.nlm.nih.gov/34157077
https://pubmed.ncbi.nlm.nih.gov/34157077
Publikováno v:
Blood
BACKGROUND AND AIMS Fear of receiving protective vaccinations against the COVID-19 virus is high among patients with immune thrombocytopenia (ITP), an autoimmune bleeding disorder, due to uncertainty around effects on platelet count (PC) reactivity.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9f8e6f47630200f80b591d79568d5bb
http://europepmc.org/articles/PMC8701508
http://europepmc.org/articles/PMC8701508
Publikováno v:
Blood
BACKGROUND AND AIMS Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder causing low platelet counts (PC) and increased bleeding. COVID-19 vaccines are a major concern for ITP patients who fear vaccination might exacerbate their thrombocy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2e933c1a453ce313c39fcd022ca750e
http://europepmc.org/articles/PMC8701507
http://europepmc.org/articles/PMC8701507
Autor:
Eun-Ju Lee, Douglas B. Cines, Howard A. Liebman, Jecko Thachil, Craig M. Kessler, Alexandra Kruse, Michael D. Tarantino, Ashley Ray, Adrian C. Newland, Adam Cuker, Marina Beltrami Moreira, Andrew D. Leavitt, Alfred Ian Lee, Hanny Al-Samkari, Terry B. Gernsheimer, Caroline Kruse, Jennifer DiRaimo, David J. Kuter, James B. Bussel
Publikováno v:
Blood
Introduction: Cases of de novo immune thrombocytopenia (ITP), including a fatality following SARS-CoV-2 vaccination in a previously healthy recipient, led to studying its impact in pre-existing ITP. Published reports are limited but suggest that most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a74ee4ac495baf9e7e8b9f48b13e964
http://europepmc.org/articles/PMC8701617
http://europepmc.org/articles/PMC8701617
Autor:
Theresa Kinard, John K. Camoriano, Jennifer Andres, Allison C. Rosenthal, Leslie Padrnos, Adrienne Kaufman, Donald W. Northfelt, Michael T. Francisco, Jill Adamski
Publikováno v:
Blood
Introduction: Acquired thrombotic thrombocytopenic purpura (aTTP) due to an acquired deficiency in the enzyme ADAMTS13 leads to ultra-large von Willebrand multimers, thrombocytopenia and microangiopathic hemolytic anemia. Complications include microv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c16196e124718138a8fe2636ae69201
https://doi.org/10.1182/blood-2021-151964
https://doi.org/10.1182/blood-2021-151964
Autor:
Angela Maria Palladino, Cinzia Giaccherini, Chiara Ticozzi, Elisa Galimberti, Marina Marchetti, Sara Gamba, Francesca Schieppati, Luca Barcella, Laura Russo, Cristina Verzeroli, Anna Falanga, Carmen J Tartari, Silvia Bolognini
Publikováno v:
Blood
Introduction: Patients (pts) with immune thrombotic thrombocytopenic purpura (iTTP) are at high risk of severe COVID-19, therefore protection from SARS-CoV-2 by vaccination is particularly relevant in this setting, although concerns may exist on poss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6b6a90da07d2ea110dc02e027b02578
https://doi.org/10.1182/blood-2021-153606
https://doi.org/10.1182/blood-2021-153606
Autor:
Suneetha Amara
Publikováno v:
Blood
Background and Objective: Heparin-induced thrombocytopenia (HIT) can develop if immune responses to infections become pathologic in the presence of heparins. Low molecular weight heparin or unfractionated heparin are recommended for prophylaxis and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550fdbfba902dce6a96eaf57e070cf86
https://doi.org/10.1182/blood-2021-151590
https://doi.org/10.1182/blood-2021-151590
Autor:
Ilias Iosifidis, Christos Varelas, Tasoula Touloumenidou, Evdoxia Koravou, Assimina Galli-Tsinopoulou, Eleni Papadimitriou, Athanasios Evangeliou, Penelope Georgia Papayanni, Apostolia Papalexandri, Athanasios Tragiannidis, Ioanna Sakellari, Evangelia Farmaki, Maria Koutra, Elisavet Michailidou, Stefanos A. Tsiftsoglou, Emmanuel Roilides, Dimitrios I. Zafeiriou, Paraskevi Panagopoulou, Efimia Papadopoulou-Alataki, Achilles Anagnostopoulos, Eleni Gavriilaki
Publikováno v:
Blood
Background: Complement dysregulation has been documented in the molecular pathophysiology of COVID-19 and recently implicated in the relevant pediatric patient inflammatory responses. Aims: Based on our previous data in adults, we hypothesized that s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f757c8f3f7b9042739709a01729d88d
https://doi.org/10.1182/blood-2021-149382
https://doi.org/10.1182/blood-2021-149382
Autor:
Smriti Mohan, Sandra Hoang Ngo, Thomas F. Michniacki, Kelly Walkovich, Pui Y. Lee, Mark C. Hannibal, Lauren DeMeyer, Jillian Lapinski
Publikováno v:
Blood
BACKGROUND: Immune thrombocytopenia purpura (ITP) has a complex pathogenesis and may be a primary diagnosis or secondary to an underlying condition 1. Evaluation for underlying diagnoses in patients presenting with atypical features of classic ITP is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b77ccd3a2ab81cf8b84987922bbf1d51
https://doi.org/10.1182/blood-2021-153035
https://doi.org/10.1182/blood-2021-153035